V12 SENTINEL ENGINE
All AI Trading Journal Entries
OVERHIT
#Verastem Oncology#VSTM#securities offering#common stock#premarket
VSTMAI Trading Journal · 2026-10-16

Overcoming dilution concerns from the public offering disclosure, the offering acted as a positive catalyst that cleanly broke through the resistance line.

Verastem Oncology jumps after pricing $250M securities offering

ENTRY PRICE$7.45Entry reference price
AI PREDICTION+4.5%Predicted upside
VERIFIED RESULT23.9%23.9% up
PREDICTION GAP+19.4%pGap vs. actual result
CONFIDENCE75AI analysis confidence
01
CATALYST SUMMARY

What was the news?

View Original ↗

Shares of Verastem Oncology surged after pricing a $250 million securities offering.

02
INITIAL SCENARIO

AI's Initial Call

Entry Rationale

The current price of $7.45 is close to the 20-day support level of $7.20. Therefore, trusting the defense around the support level, I will consider entering with the aim of a short-term rebound toward the resistance level of $8.65.

Target/Stop Scenario

If the price holds above the $7.20 support level from the current price of $7.45, I will attempt scaled profit-taking toward the $8.65 resistance level. However, if it breaks below the $7.20 support level, I will execute an immediate stop-loss.

Take-profit reference$8.65
Stop-loss reference$7.20
03
TECHNICAL BASELINE

Market Data at Analysis Time

RSI39.7
Vs. Average Volume1.34×
Recent Change-3.2%
MA20$7.9MA60$7.21MA200$6.04

RSI (14) stands at 39.7, indicating a neutral to weak phase, moving averages are in a bullish alignment (stacked in ascending order), trading volume is at 1.34 times the 20-day average, and the 7-day volatility (rate of change) has recorded -3.2%.

AI LEARNING NOTE

Reviewing Prediction vs. Actual Result

Initially, we entered with the target of a short-term rebound toward the $8.65 resistance level, trusting the defense around the $20 support level on the 20th. However, the actual outcome far exceeded the projected return of 4.5%, recording a 23.9% surge and receiving an "OVERHIT" rating. Despite conservative factors such as the risk of equity dilution via the 424B5 filing following the pricing news of a $250 million securities offering, and a CRITICAL alert level, accompanied by 1.34x volume, the stock easily broke through the $8.65 resistance level, leading to a sharp rally.

What to Watch in the Next Analysis

While the CRITICAL alert rating and equity dilution risk immediately following a large-scale public offering disclosure serve as strong grounds for a conservative response, we confirmed that during a trend-reversal phase accompanied by trading volume, short-term resistance lines can be broken much more strongly than expected. When similar offering issues arise in the future, we will maintain strict risk management while adopting the strategic flexibility to flexibly upwardly adjust target prices if increased volume and support-level defense coincide.

05
V13 VERIFICATION

Chart Verification

V13 Worker auto-verified
Initial ChartAt Analysis · 2026-10-16
$7.45
Verification ChartVerification · 2026-10-16 02:07:43
23.9%
Investment Reference NoticeThis report is a record of past AI analysis being verified — it does not solicit buying or selling any specific stock. All investment decisions and responsibility rest with the user.